These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1264656)

  • 21. [Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin].
    Brogard JM; Frankhauser J; Stahl A
    Schweiz Med Wochenschr; 1973 Mar; 103(11):404-10. PubMed ID: 4691800
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of acute urate nephropathy].
    Engelhardt R; von der Thann M; Löhr GW
    Med Welt; 1980 Oct; 31(40):1450-4. PubMed ID: 7464501
    [No Abstract]   [Full Text] [Related]  

  • 23. [New trend in gout treatment. Clinical and biological study of urate oxidase].
    Mizon JP; Plaquet R; Gentit F; Quiret JC
    Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with a new uricolytic agent].
    Alessandri C; Violi F; Bonavita MS
    Recenti Prog Med; 1986 Mar; 77(3):147-8. PubMed ID: 3715181
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypo-uricemia].
    Bontoux D
    Rev Prat; 1989 Oct; 39(23):2079-82. PubMed ID: 2814280
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperuricemia resistant to urate oxidase. Efficacy of high doses].
    Escudier B; Leclercq B; Tandonnet F; Nitenberg G
    Presse Med; 1984 May; 13(21):1340. PubMed ID: 6233569
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of precipitating anti-urate oxidase antibodies in urate oxidase-resistant hyperuricemia].
    Mourad G; Cristol JP; Chong G; Andary M; Mion C
    Presse Med; 1984 Nov; 13(42):2585. PubMed ID: 6239266
    [No Abstract]   [Full Text] [Related]  

  • 28. [Uric acid and its metabolism].
    Kissel P; Royer R
    Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
    [No Abstract]   [Full Text] [Related]  

  • 29. Current therapy for acute leukemia in childhood.
    Greene T
    Nurs Clin North Am; 1976 Mar; 11(1):3-19. PubMed ID: 1062771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperuricemia resistant to urate oxidase. Role of anti-serum urate oxidase precipitating antibodies].
    Sibony G; North ML; Bergerat JP; Lang JM; Oberling F
    Presse Med; 1984 Feb; 13(7):443. PubMed ID: 6230621
    [No Abstract]   [Full Text] [Related]  

  • 31. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urate oxidase in pediatrics].
    Dumas R; Castel J; Jean R
    Pathol Biol (Paris); 1973 Apr; 21(4):425-9. PubMed ID: 4576180
    [No Abstract]   [Full Text] [Related]  

  • 33. [Usefulness of uric acid clearance determination in the evaluation of treatment of acute leukemia].
    Kordecki H; Urasiński I; Wojdyła M
    Pol Tyg Lek; 1978 Jan; 33(1):17-9. PubMed ID: 643697
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anuria with hyperuricemia revealing acute leukemia. Treatment with urate oxidase].
    Saint-Hillier Y; Colomb H; Perol C; Bosset JF; Rozenbaum A; Dupond FL; Leconte des Floris R
    Nouv Presse Med; 1977 May; 6(21):1880-1. PubMed ID: 267278
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gout. Clinical aspects, pathogenesis, current treatment].
    Galmiche P
    Cah Med; 1971 Apr; 12(6):403-13. PubMed ID: 4934051
    [No Abstract]   [Full Text] [Related]  

  • 36. Sample preparation in patients receiving uric acid oxidase (rasburicase) therapy.
    Lim E; Bennett P; Beilby J
    Clin Chem; 2003 Aug; 49(8):1417-9. PubMed ID: 12881465
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute hyperuricemic kidney diseases in malignant hemopathies].
    Mirouze J; Vallat G; Mion C; Izarn P; Jullien C
    J Urol Nephrol (Paris); 1970; 76(4):367-76. PubMed ID: 5467868
    [No Abstract]   [Full Text] [Related]  

  • 38. Perchloric acid treatment to stabilize uric acid concentrations in blood samples of patients receiving uric acid oxidase (rasburicase) therapy.
    Stove V; Wuyts B; Delanghe J
    Clin Chem; 2007 Feb; 53(2):369-70. PubMed ID: 17259256
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hyperuricemia caused by cytostatic drugs and treated with Milurit].
    Demény P
    Orv Hetil; 1973 Feb; 114(7):384-6. PubMed ID: 4510204
    [No Abstract]   [Full Text] [Related]  

  • 40. [Urate nephropathy--complication of cytostatic therapy].
    Dolezel Z; Stejskal J; Habancová M; Dostálková D
    Cesk Pediatr; 1986 Feb; 41(2):105-7. PubMed ID: 3955742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.